NASDAQ$AVXL
Anavex Life Sciences Corp · Q1 2025 earnings
Q1 2025 earnings · · Before market open · Investor relations
Briefing
AVXL Q1 2025 — n/d revenue, 14.00 EPS
To the extent there are material differences between the estimates and the actual results, future results of operations will. Anavex Life Sciences Corp reported Q1 2025 results. Diluted EPS came in at 14.00. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Diluted EPS: 14.00.
- Filed on Form 10-Q (accession 0001731122-25-000205).
Headline financials
Revenue & EPS history
Anavex · Revenue · Quarterly
$0
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2025
+0.4%
Avg return
Earnings day
+4.0%
Avg return
5 days after
+7.1%
Avg return
30 days after
43%
28 / 65 earnings
Positive
+26.0%
Q4 2024
Best reaction
-24.8%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -5.9% | +8.4% | — | |
| Q1 2026 | +6.1% | -4.1% | +13.4% | |
| Q4 2025 | +12.4% | +24.4% | +20.8% | |
| Q3 2025 | -4.9% | -12.4% | -15.6% | |
| Q2 2025 | -1.3% | +1.2% | +24.2% | |
| Q1 2025 | +4.9% | +2.8% | +13.8% | |
| Q4 2024 | +26.0% | +40.3% | +15.8% | |
| Q3 2024 | -5.7% | -2.2% | -13.8% | |
| Q2 2024 | +2.7% | +16.2% | +4.3% | |
| Q1 2024 | -1.7% | +6.0% | -5.9% | |
| Q4 2023 | -4.1% | +7.1% | +40.2% | |
| Q3 2023 | +22.0% | +14.8% | +0.4% | |
| Q2 2023 | +11.3% | +8.2% | +9.9% | |
| Q1 2023 | -1.6% | -5.1% | -12.9% | |
| Q4 2022 | -24.8% | +1.3% | -31.1% | |
| Q3 2022 | +1.9% | +1.7% | -12.9% | |
| Q2 2022 | -3.7% | +13.2% | +12.5% | |
| Q1 2022 | +13.9% | +9.2% | -1.2% | |
| Q4 2021 | +8.2% | +13.7% | +8.5% | |
| Q3 2021 | +8.6% | +7.4% | +3.9% | |
| Q2 2021 | +7.3% | +10.6% | +50.0% | |
| Q1 2021 | -3.4% | -3.3% | +2.6% | |
| Q4 2020 | -4.2% | -6.1% | +4.9% | |
| Q3 2020 | -7.7% | -13.7% | -16.4% | |
| Q2 2020 | +4.5% | +18.9% | +17.1% | |
| Q1 2020 | +5.6% | +12.4% | +7.9% | |
| Q4 2019 | -2.0% | +0.4% | +23.8% | |
| Q3 2019 | +5.5% | -0.4% | +12.2% | |
| Q2 2019 | -1.3% | -1.3% | -4.2% | |
| Q1 2019 | +13.0% | +19.2% | +36.1% | |
| Q4 2018 | -3.8% | -10.4% | -5.2% | |
| Q3 2018 | -5.5% | -3.8% | -7.6% | |
| Q2 2018 | -0.9% | +4.5% | +70.0% | |
| Q1 2018 | -8.4% | -11.2% | +4.6% | |
| Q4 2017 | -13.3% | -14.6% | -10.3% | |
| Q3 2017 | -6.3% | -10.0% | +22.1% | |
| Q2 2017 | -3.6% | -0.5% | -1.2% | |
| Q1 2017 | +5.7% | +12.2% | +3.1% | |
| Q4 2016 | -2.8% | -6.2% | -6.2% | |
| Q3 2016 | +22.1% | +9.6% | -0.7% | |
| Q2 2016 | -10.9% | — | — | |
| Q1 2016 | -20.0% | — | — | |
| Q4 2015 | -21.8% | — | — | |
| Q3 2015 | +13.9% | — | — | |
| Q2 2015 | -5.3% | — | — | |
| Q1 2015 | +0.9% | — | — | |
| Q4 2014 | +17.6% | — | — | |
| Q3 2014 | +4.2% | — | — | |
| Q2 2014 | -8.3% | — | — | |
| Q1 2014 | -9.7% | — | — | |
| Q4 2013 | +0.0% | — | — | |
| Q3 2013 | +1.4% | — | — | |
| Q2 2013 | +8.2% | — | — | |
| Q1 2013 | +5.6% | — | — | |
| Q4 2012 | -1.3% | — | — | |
| Q3 2012 | -17.6% | — | — | |
| Q2 2012 | +0.0% | — | — | |
| Q1 2012 | +14.4% | — | — | |
| Q4 2011 | -3.8% | — | — | |
| Q3 2011 | -0.9% | — | — | |
| Q2 2011 | -8.2% | — | — | |
| Q1 2010 | -1.6% | — | — | |
| Q4 2010 | -0.3% | — | — | |
| Q3 2010 | +0.9% | — | — | |
| Q2 2010 | +1.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro